Invention Grant
- Patent Title: Universal platform to enhance CRISPR-based gene editing for in vivo therapies
-
Application No.: US18327373Application Date: 2023-06-01
-
Publication No.: US12077771B2Publication Date: 2024-09-03
- Inventor: Samira Kiani , Mo Reza Ebrahimkhani , Jennifer Chapman
- Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
- Applicant Address: US AZ Scottsdale
- Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
- Current Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
- Current Assignee Address: US AZ Scottsdale
- Agency: Quarles & Brady, LLP
- Main IPC: C12N15/85
- IPC: C12N15/85 ; C12N9/22 ; C12N15/11 ; C12N15/115 ; C12N15/62 ; C12N15/90

Abstract:
Aspects of the disclosure relate to methods and synthetic regulatory systems for more efficient nuclease-mediated homology-directed repair (HDR). In particular, provided herein are methods for more efficient in vivo and in vitro HDR-based gene editing where the methods comprise introducing into a cell a synthetic regulatory system comprising Cas nuclease, guide RNAs (gRNAs) having various lengths and configured to target distinct nucleotide sequences for simultaneous transcriptional repression (or activation) and genome editing via double stranded break and use of a donor nucleic acid molecule as a template for repair.
Public/Granted literature
- US20240002878A1 A UNIVERSAL PLATFORM TO ENHANCE CRISPR-BASED GENE EDITING FOR IN VIVO THERAPIES Public/Granted day:2024-01-04
Information query
IPC分类: